Intagesic 50 mg/325 mg Tablet is a combination analgesic and anti-inflammatory medication containing Diclofenac 50 mg and Paracetamol 325 mg. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), leading to decreased synthesis of prostaglandins, thereby reducing inflammation, pain, and fever. Paracetamol, an analgesic and antipyretic agent, acts centrally to alleviate pain and reduce fever, although its exact mechanism is not fully understood. The synergistic action of these two active ingredients provides effective relief from mild to moderate pain associated with conditions such as musculoskeletal disorders, osteoarthritis, rheumatoid arthritis, dental pain, postoperative pain, and dysmenorrhea. Intagesic is indicated for patients requiring both anti-inflammatory and analgesic therapy. It should be used with caution in individuals with a history of gastrointestinal ulcers, hepatic or renal impairment, and cardiovascular disease. Common adverse effects may include gastrointestinal discomfort, nausea, and dizziness. Patients should adhere to prescribed dosages and consult healthcare professionals before use, especially if pregnant, breastfeeding, or taking other medications. Intagesic offers a balanced approach to pain management by combining the anti-inflammatory properties of Diclofenac with the analgesic and antipyretic effects of Paracetamol.